...
机译:基于碳水化合物的癌症疫苗的最新进展
Zhejiang Univ Sch Med Shaoxing Hosp Dept Colorectal Surg Shaoxing Peoples Hosp Shaoxing 312000 Zhejiang Peoples R China;
Zhejiang Univ Sch Med Shaoxing Hosp Dept Breast &
Thyroid Surg Shaoxing Peoples Hosp Shaoxing 312000 Zhejiang Peoples R China;
Hangzhou Med Coll Peoples Hosp Zhejiang Prov Peoples Hosp Key Lab Tumor Mol Diag &
Individualized Med Zheji Hangzhou 310014 Zhejiang Peoples R China;
Hangzhou Med Coll Peoples Hosp Zhejiang Prov Peoples Hosp Key Lab Tumor Mol Diag &
Individualized Med Zheji Hangzhou 310014 Zhejiang Peoples R China;
Zhejiang Univ Sch Med Shaoxing Hosp Dept Colorectal Surg Shaoxing Peoples Hosp Shaoxing 312000 Zhejiang Peoples R China;
Hangzhou Med Coll Peoples Hosp Zhejiang Prov Peoples Hosp Dept Gastroenterol Hangzhou 310014 Zhejiang Peoples R China;
Hangzhou Med Coll Peoples Hosp Zhejiang Prov Peoples Hosp Key Lab Tumor Mol Diag &
Individualized Med Zheji Hangzhou 310014 Zhejiang Peoples R China;
Cancer vaccines; Carbohydrate; Immunotherapy; Tumor-associated carbohydrate antigens;
机译:基于碳水化合物的癌症疫苗的最新进展
机译:通过扩展的环加成化学合成基于碳水化合物的抗癌疫苗的潜在有价值的进展
机译:基于碳水化合物的疫苗的突破:一种疫苗针对癌细胞和癌症干细胞上的三个独特的聚糖表位
机译:大剂量化学疗法和自体干细胞拯救治疗的Theratope(STn-KLH)癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果:自体移植后的Theratope(STn-KLH)癌症疫苗
机译:基于碳水化合物的新型抗癌和抗菌疫苗
机译:具有糖脂佐剂的基于碳水化合物的疫苗可用于乳腺癌
机译:通过延长环加成化学合成碳水化合物抗癌疫苗的潜在有价值的进展。